Handheld biopen prints human cartilage

A handheld “biopen” capable of 3D printing cartilage tissue could for the first time be used during surgery to treat cartilage injuries and osteoarthritis. The extrusion-based device, which prints live stem cells embedded in a hydrogel material, produces constructs that look and behave just like natural articular tissue (Biofabrication 10 045006). 

“This is in stark contrast to conventional reparative cartilage made of fibrocartilage, which is very different in structure to physiological cartilage, inferior in quality and not durable,” say the researchers, a multidisciplinary team that includes surgeons, biologists, physicists and engineers. “Our technique and the scaffolds we are able to produce provide much hope for treating patients suffering from cartilage injuries and osteoarthritis.” 

Cartilage is a highly specialized tissue that has so far proved difficult to replicate using conventional tissue engineering techniques. Its special mechanical properties arise from the fact that it contains only a few cells, does not contain blood vessels, and has a distinct 3D collagen fibre structure comprising aggregated proteoglycans in an organized matrix.  

While some success has been reported for surgical treatments that exploit engineered cartilage tissue, existing procedures require two separate operations: one to remove the damaged tissue, and another to replace the tissue once it is repaired. What’s more, surgeons report a high failure rate – partly because pre-fabricated scaffolds might not perfectly match the defect, and partly because the implanted tissue is not similar enough to natural cartilage to survive for long inside the body.

Researchers believe that treatments using human stem cells could offer a solution, but few studies have been reported to date. In this new work, reported in the journal Biofabrication, scientists from the University of Melbourne, the University of Wollongong and the St Vincent’s Hospital of Melbourne provide in vitro evidence that their new biopen could enable human stem cells to be 3D printed inside the operating theatre. The ultimate aim is to enable surgeons to “sculpt” patient-specific structures in real time, creating scaffolds that perfectly match the geometry of the defect and achieve the best possible contact between the bioscaffold and the host tissue.

By Belle Dumé | physicsworld

Image Credit: C Onofrillo


About Peter Coffaro 629 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.